Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion type Assertion NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_head.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion description "[Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_provenance.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion evidence source_evidence_literature NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_provenance.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion SIO_000772 25522765 NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_provenance.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion wasDerivedFrom befree-2016 NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_provenance.
- NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_assertion wasGeneratedBy ECO_0000203 NP1249312.RA44fbApSrS82VB64Q9tb2ugw7FRbxAzvyHNGcN8Dzx9Q130_provenance.